Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity-Reference-Cited by-同舟云学术

Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity

Published:2010-02-26 Issue:2 Volume:6 Page:e1000782
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Joosten Simone A.,van Meijgaarden Krista E.,van Weeren Pascale C.,Kazi Fatima,Geluk Annemieke,Savage Nigel D. L.,Drijfhout Jan W.,Flower Darren R.,Hanekom Willem A.,Klein Michèl R.,Ottenhoff Tom H. M.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference61 articles.

1. Global Tuberculosis Control.,2004

2. Modern vaccines. Mycobacterial diseases.;PE Fine;Lancet,1990

3. Overcoming the global crisis: “yes, we can”, but also for TB …?;TH Ottenhoff;Eur J Immunol,2009

4. Envisioning future strategies for vaccination against tuberculosis.;SH Kaufmann;Nat Rev Immunol,2006

5. How can immunology contribute to the control of tuberculosis?;SH Kaufmann;Nat Rev Immunol,2001

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies;Frontiers in Immunology;2024-09-05

2. Mtbspecific HLA-E restricted T cells are induced duringMtbinfection but not after BCG administration in non-human primates and humans;2024-08-26

3. A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing;2024-07-11

4. BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors;Scientific Reports;2024-06-07

5. Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?;Best Practice & Research Clinical Haematology;2024-06